Lemaitre Vascular (LMAT) 13.74 $LMAT Myriad Genetics:

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 12:08 PM

Lemaitre Vascular (LMAT) 13.74 $LMAT

Myriad Genetics: Study Data Drives Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:51AM CDT
Most recent study data from the Nova trial shows Myriad's (MYGN) myChoice HRD test's effectiveness in detecting an increased number of ovarian cancer patients
BSX: 23.88 (-0.02), ICUI: 116.21 (+1.21), MYGN: 32.20 (+0.51), LMAT: 13.74 (+0.04)

Illumina, MolecularMD to Co-Develop Oncology Diagnostics
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:07AM CDT
The collaboration will combine Illumina's (ILMN) expertise in NGS technology with MolecularMD's experience in developing molecular testing for new oncology drugs
BSX: 23.88 (-0.02), ICUI: 116.21 (+1.21), LMAT: 13.74 (+0.04), ILMN: 140.60 (-0.65)

STERIS: Synergy Health Deal to Drive Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:05AM CDT
Management expects the Synergy acquisition to contribute $640 million to $650 million in revenues to STERIS' (STE) operations in fiscal 2017.
BSX: 23.88 (-0.02), ICUI: 116.21 (+1.21), STE: 69.43 (+0.27), LMAT: 13.74 (+0.04)

Medtronic Positive on HeartWare Buy, Covidien Synergies
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:25AM CDT
On Jun 28, 2016, we issued an updated research report on Medtronic plc (MDT).
ICUI: 116.21 (+1.21), MDT: 88.75 (+0.39), LMAT: 13.74 (+0.04), NUVA: 62.19 (+1.37)

Bruker Poised on Product Launches amid Near-Term Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:12AM CDT
On Jun 29, we issued an updated research report on Bruker Corporation (BRKR).
ICUI: 116.21 (+1.21), LMAT: 13.74 (+0.04), BRKR: 24.11 (+0.43), NUVA: 62.19 (+1.37)

Medtronic to Boost Heart Failure Business with HeartWare Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 7:11AM CDT
Medtronic (MDT) recently entered into a merger agreement with Heartware International for the treatment of advanced heart failure.
ICUI: 116.21 (+1.21), MDT: 88.75 (+0.39), LMAT: 13.74 (+0.04), HTWR: 57.75 (+0.11)

Genomic Health: Can the Liquid Biopsy Test Boost Margins?
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:50AM CDT
Genomic Health (GHDX) recently launched a next-generation sequencing blood-based mutational panel -- Oncotype SEQ Liquid Select.
BSX: 23.88 (-0.02), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), GHDX: 27.80 (-0.32)

FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 6:31AM CDT
With surgical procedures gaining ground in the treatment of drug-resistant epilepsy, the FDA go-ahead will expand Medtronic's (MDT) footprint in the billion-dollar neurosurgical market.
ICUI: 116.21 (+1.21), MDT: 88.75 (+0.39), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04)

Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 116.21 (+1.21), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), HOLX: 35.86 (-0.07)

Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 81.94 (+0.14), LMAT: 13.74 (+0.04), STJ: 80.84 (+0.26), NUVA: 62.19 (+1.37)

Qiagen's Q1 Results Hit by Currency, Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:32AM CDT
Qiagen (QGEN) is facing increasing competition from firms that provide pre-analytical solutions and other products.
BSX: 23.88 (-0.02), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), QGEN: 22.19 (+0.04)

Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 116.21 (+1.21), LMAT: 13.74 (+0.04), NUVA: 62.19 (+1.37), HRC: 51.31 (-0.06)

Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 116.21 (+1.21), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), HOLX: 35.86 (-0.07)

AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 80.04 (+1.38), EVHC: 26.16 (+0.46), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04)

Genomic Health Brings Liquid Biopsy Test for Stage IV Cancer
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:13AM CDT
Genomic's (GHDX) Oncotype SEQ facilitates personalized treatment of patients suffering from stage four solid tumor cancer.
BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), ILMN: 140.60 (-0.65), GHDX: 27.80 (-0.32)

Qiagen???s QIAsure Test to Determine Cervical Cancer Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:33AM CDT
Qiagen's (QGEN) QIAsure accurately stratifies cervical cancer risk, which offers highly sensitive and specific results for patients and clinicians.
BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), QGEN: 22.19 (+0.04), NUVA: 62.19 (+1.37)

Boston Scientific: NICE Backs GreenLight XPS for BPH Cure
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:01AM CDT
As per NICE's estimates, broad adoption of Boston Scientific's (BSX) GreenLight therapy over TURP can lead to savings of up to ??3.2 million annually for the National Health Service (NHS).
BSX: 23.88 (-0.02), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04), NUVA: 62.19 (+1.37)

Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 116.21 (+1.21), LMAT: 13.74 (+0.04), BRKR: 24.11 (+0.43), NUVA: 62.19 (+1.37)

Boston Scientific: Restructuring Plan, Global Growth Impress
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 6:14AM CDT
On Jun 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 23.88 (-0.02), ICUI: 116.21 (+1.21), BAX: 46.70 (+0.05), LMAT: 13.74 (+0.04)

PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 116.21 (+1.21), PETS: 19.31 (+0.07), LMAT: 13.74 (+0.04), NUVA: 62.19 (+1.37)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palm Beach Royals Boost Pickleball's Popularity Surge

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Hilarity and Hassles in NYC Co-op Life Exposed in New Book

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Aging at Home: The Real Costs and Obstacles Ahead

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Travelers Turn to Direct Booking Amid Cost Surge

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

TRIMAX Poised to Meet AI-Driven Power Challenges

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Dan Brown Joins Guidewire: Big Moves in P&C Software

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

ProClad Unveils Innovative Hybrid 2.0 Cookware

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

GL1F Crypto: A Breakthrough in On-Chain AI for Crypto

The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...

Metropolitan Dermatology's Strategic Expansion into Barnegat

Diving into Barnegat's Dermatology Landscape Metropolitan Dermatology has taken a strategic step by opening a new location right in the heart of Barnegat, New Jersey. Talk about a win-win for the folks in Ocean County. This isn't just another clinic opening up shop; it's about bringing comprehensive medical and surgical dermatologic care straight to the people who need...